Clinical Trial Update: An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the effectiveness and safety of decitabine in patients with myelodysplastic syndrome has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Myelodysplastic Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-12-13